top of page

Publications

Original Article

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

Tumor Microenvironment

2008

Authors:

Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML and Knutson KL

Journal:

Blood

Volume:

111(3)

Page:

1472-9

Original Article

His-tag ELISA for the detection of humoral tumor-specific immunity

Cancer Diagnostics

2008

Authors:

Goodell V, McNeel D and Disis ML

Journal:

BMC Immunology

Volume:

9

Page:

23

Original Article

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer

Cancer Vaccines

2008

Authors:

Park KH, Gad E, Goodell V, Dang Y, Wild T, Higgins D, Fintak P, Childs J, Dela Rosa C, Disis ML

Journal:

Cancer Research

Volume:

68(20)

Page:

8400-9

Review Article

Translational Research Working Group developmental pathway for immune response modifiers

2008

Authors:

Cheever MA, Schlom J, Weiner LM, Lyerly HK, Disis ML, Greenwood A, Grad O, Nelson WG; Translational Research Working Group.

Journal:

Clinical Cancer Research

Volume:

14(18)

Page:

5692-9

Original Article

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity

Cancer Vaccines

2008

Authors:

Goodell V, Waisman J, Salazar LG, dela Rosa C, Link J, Coveler AL, Webster W, Childs JS, Fintak PA, Higgins DM and Disis ML

Journal:

Molecular Cancer Therapeutics

Volume:

7(3)

Page:

449-54

Original Article

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer

Cancer Vaccines

2008

Authors:

Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL

Journal:

Cancer Research

Volume:

68(12)

Page:

4893-901

Original Article

Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature

T Cell Function & Therapy

2007

Authors:

Inokuma M, delaRosa C, Schmitt C, Haaland P, Siebert J, Petry D, Tang MX, Suni MA, Ghanekar SA, Gladding D, Dunne JF, Maino VC, Disis ML and Maecker HT

Journal:

The Journal of Immunology

Volume:

179(4)

Page:

2627-33

Methods

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses

Measuring Human Immunity

2007

Authors:

Goodell V, dela Rosa C, Slota M, MacLeod B and Disis ML

Journal:

BMC Immunology

Volume:

8

Page:

21

Original Article

Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming

T Cell Function & Therapy

2007

Authors:

Dang Y, Knutson KL, Goodell V, dela Rosa C, Salazar LG, Higgins D, Childs J, Disis ML

Journal:

Clinical Cancer Research

Volume:

13(6)

Page:

1883-91

Review Article

CD4 regulatory T cells in human cancer pathogenesis

General Immune Research

2007

Authors:

Knutson KL, Disis ML, Salazar LG.

Journal:

Cancer Immunology Immunotherapy

Volume:

56(3)

Page:

271-85

bottom of page